Page last updated: 2024-08-24

colestipol and Coronary Artery Disease

colestipol has been researched along with Coronary Artery Disease in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19903 (18.75)18.7374
1990's11 (68.75)18.2507
2000's2 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azen, SP; LaBree, L; Lapuerta, P1
Azen, SP; Cashin-Hemphill, L; Hodis, HN; Johnson, R; LaBree, L; Mack, WJ; Sevanian, A1
Davies, G; Kitano, Y; Maher, VM; Matthews, S; Mir, A; Neuwirth, C; Prescott, RJ; Rees, A; Shortt, MB; Thompson, GR1
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Hodis, HN; LaBree, L; Mack, WJ; Selzer, RH; Shircore, AM1
Brown, BG; Brunzell, JD; Hokanson, JE; Zambon, A1
Hodis, HN; Mack, WJ; Selzer, RH; Xiang, M1
Hodis, HN; LaBree, L; Liu, C; Mack, WJ; Selzer, RH1
Azen, SP; Blankenhorn, DH; Crawford, DW; Lee, PL; Mack, WJ; Pogoda, J; Selzer, RH; Shircore, AM1
Azen, SP; Blankenhorn, DH; Lee, PL; Mack, WJ; Pogoda, JM; Selzer, RH; Shircore, AM1
Brown, BG1
Diehl, JC; Havel, RJ; Kane, JP; Malloy, MJ; Phillips, NR; Ports, TA1
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Mack, WJ; Pogoda, JM; Sanmarco, ME1
Alaupovic, P; Azen, SP; Blankenhorn, DH; Chin, HP; Wickham, E1
Dereviacki, BE; Forti, N; Giannini, SD1
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Johnson, RL; Nessim, SA; Sanmarco, ME1

Reviews

1 review(s) available for colestipol and Coronary Artery Disease

ArticleYear
[The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis].
    Arquivos brasileiros de cardiologia, 1988, Volume: 51, Issue:1

    Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Artery Disease; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Probucol

1988

Trials

13 trial(s) available for colestipol and Coronary Artery Disease

ArticleYear
Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis.
    JAMA, 1995, Jun-21, Volume: 273, Issue:23

    Topics: Adult; Analysis of Variance; Antioxidants; Ascorbic Acid; Colestipol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Diet, Atherogenic; Food, Fortified; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Vitamin E

1995
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
    Lancet (London, England), 1995, Apr-01, Volume: 345, Issue:8953

    Topics: Adult; Blood Component Removal; Cholestyramine Resin; Colestipol; Coronary Angiography; Coronary Artery Disease; Data Interpretation, Statistical; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Lipoprotein(a); Lipoproteins, LDL; Lovastatin; Middle Aged; Odds Ratio; Simvastatin

1995
Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study.
    Circulation, 1996, Jan-01, Volume: 93, Issue:1

    Topics: Adult; Colestipol; Coronary Angiography; Coronary Artery Disease; Diet, Fat-Restricted; Follow-Up Studies; Humans; Hypolipidemic Agents; Male; Middle Aged; Niacin; Predictive Value of Tests

1996
Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.
    Circulation, 1999, Apr-20, Volume: 99, Issue:15

    Topics: Aged; Anticholesteremic Agents; Apolipoproteins B; Centrifugation, Density Gradient; Chemical Phenomena; Chemistry, Physical; Cholesterol, LDL; Colestipol; Combined Modality Therapy; Coronary Artery Disease; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Lipase; Lipids; Lipolysis; Lipoproteins; Liver; Lovastatin; Male; Middle Aged; Niacin

1999
Serial quantitative coronary angiography and coronary events.
    American heart journal, 2000, Volume: 139, Issue:6

    Topics: Adult; Cholesterol, LDL; Colestipol; Collateral Circulation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Death, Sudden, Cardiac; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Niacin; Prognosis; Proportional Hazards Models

2000
Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography.
    Atherosclerosis, 2000, Volume: 150, Issue:2

    Topics: Adult; Carotid Artery, Common; Carotid Stenosis; Colestipol; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Niacin; Observer Variation; Prognosis; Reproducibility of Results; Tunica Intima; Ultrasonography; Video Recording

2000
Comparison of computer- and human-derived coronary angiographic end-point measures for controlled therapy trials.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1992, Volume: 12, Issue:3

    Topics: Adult; Colestipol; Combined Modality Therapy; Computers; Coronary Angiography; Coronary Artery Disease; Humans; Male; Middle Aged; Niacin

1992
Effect of lovastatin or niacin combined with colestipol and regression of coronary atherosclerosis.
    European heart journal, 1992, Volume: 13 Suppl B

    Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Humans; Lovastatin; Male; Middle Aged; Niacin

1992
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.
    JAMA, 1990, Dec-19, Volume: 264, Issue:23

    Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Niacin; Radiographic Image Interpretation, Computer-Assisted; Triglycerides

1990
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.
    JAMA, 1990, Dec-19, Volume: 264, Issue:23

    Topics: Adult; Apolipoproteins; Cholesterol; Colestipol; Coronary Artery Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Niacin; Radiography

1990
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.
    Circulation, 1990, Volume: 81, Issue:2

    Topics: Apolipoprotein C-III; Apolipoproteins; Apolipoproteins C; Colestipol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Humans; Lipids; Male; Middle Aged; Multivariate Analysis; Niacin; Randomized Controlled Trials as Topic; Recurrence

1990
[The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis].
    Arquivos brasileiros de cardiologia, 1988, Volume: 51, Issue:1

    Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Artery Disease; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Probucol

1988
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.
    JAMA, 1987, Jun-19, Volume: 257, Issue:23

    Topics: Adult; Clinical Trials as Topic; Colestipol; Coronary Artery Bypass; Coronary Artery Disease; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Lipids; Male; Middle Aged; Niacin; Polyamines; Radiography; Random Allocation

1987

Other Studies

3 other study(ies) available for colestipol and Coronary Artery Disease

ArticleYear
Use of neural networks in predicting the risk of coronary artery disease.
    Computers and biomedical research, an international journal, 1995, Volume: 28, Issue:1

    Topics: Adult; Cholesterol; Colestipol; Coronary Artery Disease; Coronary Disease; Diet, Fat-Restricted; Follow-Up Studies; Forecasting; Humans; Lipids; Lipoproteins; Longitudinal Studies; Male; Middle Aged; Neural Networks, Computer; Niacin; Placebos; Randomized Controlled Trials as Topic; Regression Analysis; Reproducibility of Results; Risk Factors

1995
Evaluation of colestipol/niacin therapy with computer-derived coronary end point measures. A comparison of different measures of treatment effect.
    Circulation, 1992, Volume: 86, Issue:6

    Topics: Adult; Colestipol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Drug Therapy, Combination; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Niacin; Randomized Controlled Trials as Topic; Treatment Outcome

1992
Colestipol-niacin therapy and coronary atherosclerosis.
    JAMA, 1987, Nov-20, Volume: 258, Issue:19

    Topics: Adult; Colestipol; Coronary Artery Disease; Humans; Male; Middle Aged; Niacin; Polyamines; Research Design

1987